Skip to content
Medical Health Aged Care

Urgent Reform Needed to Sustain Voluntary Assisted Dying Services

VADANZ (Voluntary Assisted Dying Australia & NZ) 3 mins read
Key Facts:

The 2025 VADANZ Remuneration Survey of Voluntary Assisted Dying (VAD) practitioners has revealed almost two‑thirds (63%) reported their state’s remuneration arrangements were inadequate. More than a quarter (27%) said they had provided unpaid VAD care.

 


Voluntary Assisted Dying (VAD) is now a legal end‑of‑life choice in every Australian jurisdiction except the Northern Territory. Yet despite this historic legislative shift, the financial and structural support for practitioners delivering VAD remains inadequate, threatening the sustainability of services and the wellbeing of the workforce.

The 2025 VADANZ Remuneration Survey of VAD practitioners has revealed:

  • Almost two‑thirds (63%) reported their state’s remuneration arrangements were inadequate.

  • More than a quarter (27%) said they had provided unpaid VAD care.

  • Only one‑third (32%) received any state government reimbursement.

  • All respondents in South Australia and Tasmania reported dissatisfaction, as did 80% of Victorians.

  • Queensland respondents were also largely dissatisfied (72%), particularly for rural and community-based doctors facing high travel burdens.

  • New South Wales was the only jurisdiction where a slim majority (51%) felt remuneration was adequate.

VADANZ President Dr Andrea Bendrups said VAD practitioners consistently report deep professional fulfilment in providing end-of-life care and remain strongly committed to supporting patients and their families. However Dr Bendrups noted that relying on goodwill made it difficult to maintain a stable and sustainable service over time. 

“All Australian jurisdictions, apart from the Northern Territory, have taken the courageous step of legalising VAD. Person-centered services have been established in all these jurisdictions which are delivering high quality end-of-life care, but relying on clinical altruism to do so. We urgently need to ensure those who provide this care have the support they need to continue doing so,” Dr Bendrups said. 

At present, there are no dedicated Medicare items for VAD. The Medicare Benefits Schedule (MBS) excludes “euthanasia and any service directly connected to the procedure”, leaving practitioners uncompensated for extensive non‑clinical work such as administration, portal documentation, coordination, and travel.

Survey respondents told of the ethical discomfort they felt about charging privately for VAD services. However, without proper remuneration, many privately practising GPs and specialists face financial strain. Some practitioners are questioning whether they can continue providing VAD care long term.

“We are going to extraordinary lengths to shield patients from financial burden, but the system cannot rely indefinitely on the goodwill of practitioners,” Dr Bendrups said.  

“This is not only a workforce issue, it ultimately affects patient access and continuity of care.”

Reduced practitioner participation risks limiting access to a compassionate end‑of‑life option, compromising dignity and autonomy for patients.

VADANZ is calling for several reforms, including:

  • Dedicated MBS items recognising the unique demands of VAD care.

  • Comprehensive fee schedules covering all aspects of care, including travel.

  • Increased numbers of funded hospital roles to provide stability for practitioners.

  • Clear state guidance on billing options to reduce uncertainty.

  • Federal updates to MBS Explanatory Notes to remove outdated restrictions on VAD items.

Dr Bendrups said the New Zealand model offers a proven template, with structured fee‑for‑service payments across five modules, additional remuneration for complex cases, and travel allowances. This system ensures transparency and fairness, principles that underpin a sustainable system. 

“Without adequate remuneration, the system risks collapsing under the weight of unpaid labour and practitioner burnout,’’ Dr Bendrups said.

“We look forward to working constructively with policymakers to align funding structures with the realities of VAD practice.”

Read the survey

NOTES: 

The survey of VADANZ members was conducted from 16 April to 24 July, 2025. 

There were 170 respondents, representing 12% of the national workforce. Among them, 42% were general practitioners (GPs) and 45% were other specialists. The vast majority had more than 11 years’ clinical experience. 

The survey does not include the Northern Territory or the ACT because there was no VAD legislation in effect in either jurisdiction at the time the survey was conducted.

 


About us:

Voluntary Assisted Dying Australia and New Zealand (VADANZ) is the peak body for health professionals providing voluntary assisted dying (VAD) care.

 


Contact details:

Dr Andrea Bendrups, VADANZ president.

[email protected] 

Media

More from this category

  • Medical Health Aged Care
  • 24/05/2026
  • 11:45
Royal Australian College of GPs

RACGP launches five-year plan to strengthen general practice and patient care

The Royal Australian College of GPs (RACGP) has today launched its Advocacy Plan 2026–30, setting a clear, long‑term agenda to improve patient outcomes and strengthen the voice of general practice across Australia. RACGP President Dr Michael Wright said the plan reinforces the College’s commitment to patient‑centred care and calls for sustained investment in general practice and the health of our communities. “Every priority in this plan has been shaped by our members,” he said. “It reflects what GPs are telling us every day about what their patients need and what the system must do better.” The Advocacy Plan 2026–30 calls…

  • Contains:
  • Medical Health Aged Care
  • 24/05/2026
  • 05:00
Dementia Australia

Join us today for the Sydney Memory Walk & Jog

What: Dementia Australia’s SydneyMemory Walk & Jog   When: Sunday 24 May from 7:30am   Who: More than 1,450 locals participating on the day. People who have been impacted by dementia, their family, friends and carers. Special guest MC Tully Smyth.   Where: Cathy Freeman Park   Dementia Australia spokespeople and local residents are available for interview. Photos and video of previous Memory Walk & Jog events for publication are available for use. For more information visit: www.memorywalk.com.au Dementia Australia is the source of trusted information, education and services for the estimated more than 446,500 Australians living with dementia, and…

  • Contains:
  • Medical Health Aged Care
  • 23/05/2026
  • 02:33
Galderma

Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch

A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.